#Geftinat is an #anti-cancer medication containing the drug #Gefitinib as active substance in it, which is an inhibitor that interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells, thus helping in slowing down the growth of #cancer cells. #Gefitinib250mg is mainly used in treatment of non-small cell #lungcancer. You can get Geftinat manufactured by Natco at economical prices from us, Call: +91-9873336444, QQ: 152
EGFR stains using the DakoCtomation kit on colon carcinomas. Nonspecific cytoplasmic staining (left) is common, and should be ignored. - http://www.propath.com/companies/press-clippings/26-newsletters/267-epidermal-growth-factor-receptor-and-erbitux-march-2004
New breast cancer test could spare women chemotherapy
Thousands of women with breast cancer could be spared chemotherapy following NHS approval of a test which can help establish who needs the treatment and who might not...the oncotype DX test, was approved for women who have oestrogen receptor positive (ER+), lymph node negative (LN–) and human epidermal growth factor receptor 2 negative (HER2–) in early breast cancer..